Understanding how TULP1 gene mutations cause vision loss
Molecular Mechanisms of TULP1-Mediated Photoreceptor Degeneration
This study is looking at how changes in the TULP1 gene can cause early vision loss in people with retinitis pigmentosa, and it hopes to find ways to help protect eyesight by understanding how these changes affect the cells in the eye.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11077328 on NIH RePORTER |
What this research studies
This research investigates the role of the TULP1 gene in causing early-onset retinitis pigmentosa, a condition that leads to severe vision loss. The study focuses on how mutations in TULP1 disrupt the transport of essential proteins within photoreceptor cells in the retina, leading to cell death. By using mouse models, researchers aim to uncover the cellular mechanisms behind this degeneration and explore potential therapeutic targets to prevent vision loss. Patients may benefit from insights gained into the disease process and potential future treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with retinitis pigmentosa, particularly those with mutations in the TULP1 gene.
Not a fit: Patients with retinitis pigmentosa caused by mutations in genes other than TULP1 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that slow or prevent vision loss in patients with TULP1-related retinal diseases.
How similar studies have performed: Previous research has shown promising results in understanding the mechanisms of retinal degeneration, suggesting that this approach could yield valuable insights.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Hagstrom, Stephanie a — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Hagstrom, Stephanie a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.